SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-24-000206
Filing Date
2024-02-07
Accepted
2024-02-07 16:31:07
Documents
48
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e5398_10-q.htm   iXBRL 10-Q 597251
2 EXHIBIT 31.1 e5398_ex31-1.htm EX-31.1 8267
3 EXHIBIT 31.2 e5398_ex31-2.htm EX-31.2 8179
4 EXHIBIT 32.1 e5398_ex32-1.htm EX-32.1 5969
5 GRAPHIC image_001.jpg GRAPHIC 31255
6 GRAPHIC image_002.jpg GRAPHIC 28490
  Complete submission text file 0001731122-24-000206.txt   3012187

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE avxl-20231231.xsd EX-101.SCH 25297
8 XBRL CALCULATION FILE avxl-20231231_cal.xml EX-101.CAL 26927
9 XBRL DEFINITION FILE avxl-20231231_def.xml EX-101.DEF 79871
10 XBRL LABEL FILE avxl-20231231_lab.xml EX-101.LAB 194315
11 XBRL PRESENTATION FILE avxl-20231231_pre.xml EX-101.PRE 152433
49 EXTRACTED XBRL INSTANCE DOCUMENT e5398_10-q_htm.xml XML 360809
Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 980608404 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 24604761
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)